High Court Approves Puberty Blockers Trial for Children Amid Controversy
A high court judge has cleared the way for a clinical trial of puberty blockers for children, dismissing a legal challenge by campaigners who argued the trial could harm participants. The Pathways trial, conducted by King's College London, aims to recruit over 220 children aged 11 to 16 starting August 1. The trial has faced opposition from individuals like Keira Bell, who detransitioned after taking puberty blockers, and groups concerned about the ethical implications of such research. The university assures that safety measures are in place, with participants undergoing thorough assessments by specialist doctors. 
